‘Resolving the Unresolved’ Monthly Call to Resolve Complex Genetic Cases from Oncology and Rare Diseases
GenomeArc’s Initiative to Resolve Complex Unresolved Cases
MIssissauga, Ontario
GenomeArc has unveiled a pioneering initiative dedicated to addressing one of the most persistent challenges in clinical genomic medicine: unresolved genetic cases in oncology and rare disease diagnostics. Despite the advances in next-generation sequencing and molecular profiling, a significant number of patients continue to face diagnostic uncertainty due to elusive or poorly understood genetic variants. Recognizing this critical gap, GenomeArc's new initiative leverages its Horizon Intelligence platform—integrating multi-omic data, deep reanalysis pipelines, and AI-driven variant interpretation—to systematically revisit and reinterpret complex cases.
Through strategic collaborations with leading academic institutions, clinical laboratories, and healthcare systems worldwide, GenomeArc is not only enhancing the resolution of difficult cases but also democratizing access to high-resolution genomic insights. This initiative holds the potential to transform patient outcomes by delivering clearer diagnostic answers, enabling more precise therapeutic decisions, and accelerating the journey toward personalized medicine.
Registration for monthly call on complex genetic case studies:
Monthly calls will be held to present complex clinical genomic cases that remain diagnostically unresolved. All participants are required to register using their institutional affiliation and email.
To enroll your complex case into the program, please email: project@genomearc.com
Learn more about “Resolving the Unresolved” initiative: https://genomearc.com/blog-show/MjY6OlRhbnZpclNS
GenomeArc Inc. is a biotech company on clinical genetics and drug discovery headquartered in Mississauga, Ontario. The company began its journey in 2021, GenomeArc develops artificial intelligence integrated solutions for genetic diagnosis and genomic drug development solutions for rare genetic disorders and pan cancer. As a research-oriented biotech company, GenomeArc brings new insights into rare diseases, cancer diagnosis, and therapeutics through genome analysis. The GenomeArc team is constantly innovating technologies to solve phenotypic complexities in genetic variations for rapid intervention. As a global company, our aim is to make efficient and accurate genome medicine technologies accessible for all healthcare systems.
See more Blogs: